BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salmaso V, Jacobson KA. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design. ChemMedChem 2020;15:1958-73. [PMID: 32803849 DOI: 10.1002/cmdc.202000465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Di Virgilio F, Jacobson KA, Williams M. Geoffrey Burnstock - An accidental pharmacologist. Biochem Pharmacol 2021;187:114300. [PMID: 33203518 DOI: 10.1016/j.bcp.2020.114300] [Reference Citation Analysis]
2 Gad AA, Azimzadeh P, Balenga N. Conserved residues in the extracellular loop 2 regulate Stachel-mediated activation of ADGRG2. Sci Rep 2021;11:14060. [PMID: 34234254 DOI: 10.1038/s41598-021-93577-y] [Reference Citation Analysis]
3 Wang J, Bhattarai A, Do HN, Akhter S, Miao Y. Molecular Simulations and Drug Discovery of Adenosine Receptors. Molecules 2022;27:2054. [PMID: 35408454 DOI: 10.3390/molecules27072054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Carini M, De Amici M. 2020 Italian Special Anniversary Collection: Celebrating NMMC 2019 and 40 Years of the DCF-SCI. ChemMedChem 2021;16:303-8. [PMID: 33354905 DOI: 10.1002/cmdc.202000926] [Reference Citation Analysis]
5 Salmaso V, Jain S, Jacobson KA. Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization. Methods Cell Biol 2021;166:133-59. [PMID: 34752329 DOI: 10.1016/bs.mcb.2021.06.001] [Reference Citation Analysis]
6 Strassheim D, Sullivan T, Irwin DC, Gerasimovskaya E, Lahm T, Klemm DJ, Dempsey EC, Stenmark KR, Karoor V. Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases. Cells 2021;10:3347. [PMID: 34943862 DOI: 10.3390/cells10123347] [Reference Citation Analysis]
7 Mori A, Chen JF, Uchida S, Durlach C, King SM, Jenner P. The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease. Molecules 2022;27:2366. [PMID: 35408767 DOI: 10.3390/molecules27072366] [Reference Citation Analysis]
8 Barresi E, Martini C, Da Settimo F, Greco G, Taliani S, Giacomelli C, Trincavelli ML. Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications. Front Pharmacol 2021;12:652121. [PMID: 33841166 DOI: 10.3389/fphar.2021.652121] [Reference Citation Analysis]
9 Raines R, Mcknight I, White H, Legg K, Lee C, Li W, Lee PHU, Shim JW. Drug-Targeted Genomes: Mutability of Ion Channels and GPCRs. Biomedicines 2022;10:594. [DOI: 10.3390/biomedicines10030594] [Reference Citation Analysis]
10 Rovati G, Contursi A, Bruno A, Tacconelli S, Ballerini P, Patrignani P. Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis. Cells 2022;11:725. [PMID: 35203374 DOI: 10.3390/cells11040725] [Reference Citation Analysis]